Key result
Adipose-specific MTP knockout reduces hepatic steatosis versus wild-type mice on an obesogenic diet.
Why the study?
Metabolic dysfunction-associated steatotic liver disease is a growing health issue, and the impact of adipose microsomal triglyceride transfer protein deficiency on MASLD was unknown.
p-value: p=0.0076
Adipose-specific MTP deficiency protects against hepatic steatosis by upregulating hepatic PPARα activity via enhanced adipose-liver fatty acid crosstalk.
No takes yet. Share an insight, caveat, or question.
Adipose MTP deficiency attenuates steatosis in obese mice; hypothesis-generating for human MASLD and requires translational studies.
Rajan et al. (2025) studied Metabolic dysfunction-associated steatotic liver disease (MASLD) (n=8). Adipose MTP deficiency (A-Mttp-/-) vs. Wild-type mice was evaluated on Hepatic steatosis and plasma triglyceride levels (p=0.0076). Adipose-specific MTP knockout mice on an obesogenic diet exhibited less hepatic steatosis compared to wild-type mice (p=0.0076).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: